Molecular biology of human melanoma development and progression (Q77619102)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833774 AND SRC:MED&resulttype=core&format=json

7 December 2019

review article

1 reference

title

Molecular biology of human melanoma development and progression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833774 AND SRC:MED&resulttype=core&format=json

7 December 2019

0 references

E R Sauter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833774 AND SRC:MED&resulttype=core&format=json

7 December 2019

M Herlyn

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833774 AND SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833774 AND SRC:MED&resulttype=core&format=json

7 December 2019

published in

Molecular Carcinogenesis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833774 AND SRC:MED&resulttype=core&format=json

7 December 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833774 AND SRC:MED&resulttype=core&format=json

7 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833774 AND SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

132-143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833774 AND SRC:MED&resulttype=core&format=json

Epidemiology and prognostic factors in malignant melanoma

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Racial differences in melanoma incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Similarities to melanoma: the Vancouver Mole Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

New directions in research Ultraviolet light and skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

The Danish case-control study of cutaneous malignant melanoma. II. Importance of UV-light exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

UVR induction of TGF alpha: a possible autocrine mechanism for the epidermal melanocytic response and for promotion of epidermal carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Induction of nerve growth factor receptors on cultured human melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Animal model for ultraviolet radiation-induced melanoma: platyfish-swordtail hybrid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Regulation of epidermal cell interleukin-6 production by UV light and corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Novel putative receptor tyrosine kinase encoded by the melanoma-inducing Tu locus in Xiphophorus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Possible involvement of the chromosome region 10q24----q26 in early stages of melanocytic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Melanoma metastases from patients with hereditary cutaneous malignant melanoma contain a high frequency of N-ras activating mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Mutational analysis of the human p53 gene in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Molecular pathology of melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Loss of expression of thep16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Restoration of CDKN2A into melanoma cells induces morphologic changes and reduction in growth rate but not anchorage-independent growth reversal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Increase in radiation sensitivity of human malignant melanoma cells by expression of wild-type p16 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Germline p16 mutations in familial melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Chromosomal and genetic alterations of 7,12- Dimethylbenz[a]anthracene–induced melanoma from TP-ras transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Human cutaneous malignant melanoma as a model for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Rashomon and the procrustean bed: a tale of dysplastic nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Tumour progression and the nature of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Cytogenetics of human malignant melanoma and premalignant lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Transformation of normal human melanocytes and non-malignant nevus cells by adenovirus 12-SV40 hybrid virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Structure, function, and clinical significance of human tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Identification of a melanoma progression antigen as integrin VLA-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Role of the alpha v beta 3 integrin in human melanoma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Identification of an amino acid sequence from the laminin A chain that stimulates metastasis and collagenase IV production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Differential patterns of HOX gene expression are associated with specific integrin and ICAM profiles in clonal populations isolated from a single human melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Identification of the S-Endo 1 endothelial-associated antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Expression of cell adhesion molecules in human melanoma cell lines and their role in cytotoxicity mediated by tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

A study of adhesion molecules as markers of progression in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Class II histocompatibility antigen expression in human melanocytes transformed by Harvey murine sarcoma virus (Ha-MSV) and Kirsten MSV retroviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Differential stimulation of collagenase and chemotactic activity in fibroblasts derived from rat wound repair tissue and human skin by growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Transforming growth factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Serum-free culture of normal human melanocytes: growth kinetics and growth factor requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factor (PDGF) and produce a PDGF-like growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Interleukin 1: the first interleukin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Evidence for alpha-melanocyte-stimulating hormone (alpha-MSH) receptors on human malignant melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

MELANOCYTE-STIMULATING HORMONE AND ADRENOCORTICOTROPHIC HORMONE. THEIR RELATION TO PIGMENTATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

The cloning of a family of genes that encode the melanocortin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Growth factor receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

The differential expression of protein kinase C genes in normal human neonatal melanocytes and metastatic melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Analysis of normal neoplastic human tissues for the tumor-associated protein p97

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Human melanoma-associated antigen p97 is structurally and functionally related to transferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Spontaneous and induced differentiation of human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Monoclonal antibody against human tyrosinase and reactive with melanotic and amelanotic melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Melanoma antigens: immunological and biological characterization and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

The melanoma proteoglycan: restricted expression on microspikes, a specific microdomain of the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Characterization of melanoma-associated surface antigens involved in the adhesion and motility of human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Expression of MAGE genes in primary and metastatic cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Antiantiidiotypic Response and Clinical Course of the Disease in Patients with Malignant Melanoma Immunized with Mouse Antiidiotypic Monoclonal Antibody MK2-23

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Melanoma vaccines. Current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Recent advances in the care of the patient with malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

The orderly progression of melanoma nodal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

Detection of Submicroscopic Lymph Node Metastases in Patients With Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833774 AND SRC:MED&resulttype=core&format=json

7 December 2019

1 reference